European equities traded in the US as American depositary receipts kicked off the week trending lower late Monday morning, declining 0.37% to 1,326.63 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Novo Nordisk (NVO), which rose 11% and 1.8% respectively. They were followed by internet browser company Opera (OPRA) and telecommunications company Ericsson (ERIC), which were up 1.7% and 0.5% respectively.
The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and furniture maker Natuzzi (NTZ), which lost 5.4% and 3.4% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and oil and gas company TotalEnergies (TTE), which dropped 3% and 2.6% respectively.
From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and cruise line operator Carnival (CUK), which were up 6.5% and 3.1% respectively. They were followed by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma Group (MREO), which rose 0.6% each.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company TC Biopharm (TCBP), which dropped 4.5% and 4.2% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company BP (BP), which were off 2.6% and 2.1% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。